Neuren Pharmaceuticals | NEU - Cost Of Sales

Stock Price
12.52
Daily Change
-0.68 -5.15%
Monthly
-31.51%
Yearly
-10.70%
Q1 Forecast
16.35

Neuren Pharmaceuticals reported AUD7.45M in Cost of Sales for its fiscal semester ending in June of 2025.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Avita Medical AUD 3.47M 1.19M Jun/2025
Clinuvel Pharmaceuticals AUD 1.93M 4.97M Jun/2024
Genetic Signatures AUD 2.31M 2.32M Jun/2025
Ionis Pharmaceuticals USD 2.34M 1.81M Sep/2025
Medical Developments International AUD 2.18M 3.09M Jun/2025
Neuren Pharmaceuticals AUD 7.45M 6.56M Jun/2025
Organon & Co USD 745M 25M Sep/2025
Paradigm Biopharmaceuticals AUD 1.88K 16.84K Jun/2025
Starpharma Holdings AUD 876K 528K Jun/2025
Telix Pharmaceuticals AUD 148.66M 10.4M Dec/2024
Viatris USD 2.39B 139.2M Sep/2025
Xeris Pharmaceuticals USD 13.71M 1.81M Sep/2025